| Description | HNRNPUL1 Human Pre-designed siRNA Set A contains three designed siRNAs for HNRNPUL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components HNRNPUL1 siRNA-1: 5 nmol (HPLC) HNRNPUL1 siRNA-2: 5 nmol (HPLC) HNRNPUL1 siRNA-3: 5 nmol (HPLC) siRNA HNRNPUL1 Human Pre-designed siRNA Set A contains three designed siRNAs for HNRNPUL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components HNRNPUL1 siRNA-1: 5 nmol (HPLC) HNRNPUL1 siRNA-2: 5 nmol (HPLC) HNRNPUL1 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | Inquire | Ganglioside GT1b is a brain ganglioside. It is composed of a neutral tetra-saccharide core, with one or two sialic acid on the internal galactose and an extra sialic acid on the non-reducing terminal of galactose | Tankyrase-IN-2 (compound 5k) is a potent, selective, and orally active tankyrase inhibitor ( IC 50 s of 10, 7, and 710 nM for TNKS1, TNKS2 as well as PARP1, respectively). Tankyrase-IN-2 has favorable physicochemical profile and pharmacokinetic properties modulating Wnt pathway activity in a Tankyrase-IN-2 (compound 5k) is a potent, selective, and orally active tankyrase inhibitor ( IC 50 s of 10, 7, and 710 nM for TNKS1, TNKS2 as well as PARP1, respectively). Tankyrase-IN-2 has favorable physicochemical profile and pharmacokinetic properties modulating Wnt pathway activity in a colorectal xenograft modelIn VitroTankyrase-IN-2 (1-10000 nM; 24 hours) leads to a dose-dependent increase of tankyrase protein abundance with an EC 50 of 320 nM in DLD1 cells. This is in the same potency range as the value for axin2 increase (EC 50 =319 nM). MCE has not independently confirmed the accuracy of these methods. They are for reference only.IC50& Target:IC50: 10 nM (TNKS1), 7 nM (TNKS2), 710 nM (PARP1)... Read More |